PurGenesis Technologies Inc.: Clinical Trials

3 completed. 2 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2
Phase 1	1	Completed 1

Follow PurGenesis Technologies Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis Administration of Placebo, Administration of PUR0110 (Thykamine) 0.05%, Administration of PUR0110 (Thykamine) 0.1% - Atopic Dermatitis Eczema	Phase 2	Completed	PurGenesis Technologies Inc.	162	2017-10-23	2021-09-16
Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis PUR 0110 Rectal Enema 250 mg, PUR 0110 Rectal Enema 500 mg, PUR 0110 Rectal Enema 1000 mg - Left-Sided Ulcerative Colitis, Proctosigmoiditis	Phase 2	Completed	PurGenesis Technologies Inc.	34	2010-06-01	2018-05-01
A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers PUR 0110 Rectal Enema or Placebo Enema - Ulcerative Colitis	Phase 1	Completed	PurGenesis Technologies Inc.	24	2009-06-01	2010-06-24

Conditions studied

Colitis, Ulcerative (1)  ·  Lymphoma, Follicular (1)  ·  Proctocolitis (1)

Countries

Germany (2)  ·  Canada (1)

Top investigators

Theophilus J Gana, MD, PhD (2)  ·  Sergej Berger, MD (1)  ·  Wei Jing Loo, MD (1)  ·  Yves Poulin, MD (1)

NIH funding

2009 (2)